capable of producing a soluble toxic substance. It is supposed that this toxic substance is absorbed from the throat and causes the general manifestations of the disease. Whether this substance is a true exotoxin similar to diphtheria toxin has not as yet been established. It is supposed, furthermore, that immunity to scarlet fever, whether existing in a normal individual or acquired by an attack of the disease is antitoxic in nature and that the presence of immunity can be determined in an individual by finding out whether or not his serum blanches the rash in a patient with scarlet fever, or whether or not he reacts to an injection of the toxic substance found in filtrates of scarlatinal streptococcus cultures.
The experimental data on which the foregoing conception of scarlet fever is based may be briefly summarized. of Streptococcus hcemolyticus from the throats of patients with scarlet fever are distinguishable immunologically from hemolytic streptococci from other sources and are themselves for the most part immunologically homologous. These observations have been independently substantiated by Tunnicliff n,I2 and by GordonY Dochez t'2 has shown, furthermore, that a disease resembling scarlet fever in many respects may be produced in guinea pigs by inoculation with scarlatinal streptococci by a method which establishes a local infection in the subcutaneous tissue of the animal. He has, in addition, produced an antiserum by immunization of a horse with living cultures of a scarlatinal streptococcus. This antiserum has been shown by Blake, Trask, and Lynch 14 to possess the same properties which human convalescent scarlet fever serum has been shown to possess; namely, the ability to blanch the scarlet fever rash at the site of an intracutaneous injection and to exert a favorable therapeutic effect on the disease. It is presumably antitoxic in character.
Dick and Dick 4'6 have succeeded in producing scarlet fever in human volunteers by inoculation of scarlatinal streptococci in the throats of the volunteers. They a have shown, furthermore, that bacteria-free filtrates of cultures of scarlatinal hemolytic streptococci contain a toxic substance which produces a local reaction when injected intracutaneously in persons supposedly susceptible to scarlet fever. This substance causes no reaction in persons who have had scarlet fever, or are supposedly immune to scarlet fever, or have been passively immunized by convalescent scarlet fever serum prior to the test with the toxic filtrate. The toxic action of the filtrate is neutralized by in vitro incubation with convalescent scarlet fever serum prior to injection in a susceptible person. Zingher I5 has repeated and substantiated these observations with the toxic filtrates of scarlatinal streptococcus cultures and has shown that the Dick test is, in many respects, analogous to the Schick test for susceptibility to diphtheria.
Mair, ~ in a study of the Schultz-Charlton 1° blanching phenomenon, has pointed out that the blanching of the scarlet fever rash by normal human serum or by convalescent scarlet fever serum may be more logically interpreted as an immunity reaction in which an antitoxin in the blanching serum neutralizes a toxin in the patient, than as a reaction due to some property of normal serum that is lost during the acute stage of scarlet fever as originally proposed by the discoverers of the phenomenon.
In order to provide further evidence in support of the foregoing conception of scarlet fever an effort has been made to determine whether a specific toxic substance could be demonstrated in the blood and urine of scarlet fever patients during the acute stage of the disease. The results of this study are presented in this paper.
Methods.
Samples of venous blood were collected from patients acutely ill with scarlet fever. After the blood had clotted, the serum was separated by centrifugation, pipetted off, and stored in the ice box in sterile bottles without preservative. Specimens of urine were filtered through Berkefeld filters and stored in a similar way. All specimens were tested for sterility before use. Tests for the presence of a toxic substance in the serum and urine samples were made by intracutaneous injections in two groups of human volunteers. Members of the first group were supposedly susceptible because it had been determined that their serums failed to blanch the rash of patients with scarlet fever. Members of the second group were supposedly insusceptible because their serums blanched the rash in patients with scarlet fever. Whenever a sample of serum or urine gave a positive local reaction, the specificity of the reaction was controlled by a neutralization test with a blanching serum. This was performed by intracutaneous injections in a known susceptible volunteer of two equal portions of the sample, one of which had been mixed with a human serum not possessing the property of blanching the rash of scarlet fever, the other of which had been mixed with a human serum possessing the property of blanching. The mixtures were incubated in a water bath at 37°C. for 30 minutes prior to injection. A few similar neutralization tests were also performed with normal horse serum in place of the non-blanching human serum and with Dochez's scarlatinal antistreptococcic serum in place of the human blanching serum. The volunteer test subjects were observed daily and the reactions obtained were studied with respect to size, duration, in-tensity of the erythema, presence of induration, development of pigmentation, and the occurrence of desquamation.
Presence of a Toxic Substance in the Blood of Persons with
Scarlet Fever.
For the preliminary tests specimens of serum from two severe cases of scarlet fever were selected.
I. Jan. 24, 1924. Blood was collected from M. R., a highly toxic case of scarlet fever, on the 3rd day of the disease. The serum, A, was separated from the clot and stored in the ice box. Feb. 16 . The 21st day of convalescence, a second sample of blood was collected, the serum, B, separated and similarly stored.
Feb. 20, 9 a.m. 0.5 cc. of Serum A was injected intracutaneously on the flexor surface of the right forearm in each of three human volunteers, A. P., R. E., and M.B. Control injections of 0.5 cc. of Serum B were similarly made on the left forearms of A. P., R. E., and M.B. Blood serum from A. P. and R. E. had failed to blanch the rash of patients with scarlet fever, serum from M. B. had produced a well marked area of blanching. In the supposedly susceptible volunteers, A. P. and R. E., Serum A produced a marked local reaction in A. P. (Fig. 1) , a definite but less severe local reaction in R. E., whereas the control Serum B produced no reaction (Fig. 2 ). In the supposedly insusceptible volunteer, M. B., neither Serum A nor Serum B produced any reaction. The character of the reactions is described in Table I. II. 0.3 cc. of Serum A obtained from a severe case of scarlet fever, J. M., late on the 5th day of the disease was injected intracutaneously in each of five human volunteers, two of whom were supposedly susceptible since their serums had failed to blanch the rash of scarlet fever, and three of whom served as supposedly insusceptible controls since their serums had produced well marked positive blanching tests. Control injections of 0.3 cc. of Serum B obtained from the same patient on the 2nd day of convalescence were also made in each subject. The result was completely negative, no reaction occurring in any of the subjects with either serum.
In spite of the negative result obtained in the second test, the first one appeared to be sufficiently definite to warrant further investigation of a series of patients with scarlet fever, especially since it seemed possible that the positive reactions obtained in the first instance might be due to the fact that the blood was collected early on the 3rd day of the disease, while the negative result in the second instance might be due to the fact that the blood was collected late on the 5th day. At any rate, if the negative outcome of the second test
be disregarded for the moment, the result of the first would seem to show that a toxic substance capable of producing a well marked local reaction in the skin of supposedly susceptible individuals, but no reaction in supposedly insusceptible individuals, can be demonstrated in the blood serum early in the course of an instance of severe scarlet fever.
To provide further evidence on this point the following procedure was carried out.
III. Single specimens of serum were obtained from 17 cases of scarlet fever of varying degrees of severity; 2 were collected on the 2nd day of the disease, 9 on the 3rd day, 5 on the 4th day, and 1 on the 5th day.
Eight human volunteers were available for intracutaneous tests with the scarlet fever serums. Four of them, Group A, had not had scarlet fever, and samples of their serums when injected intracutaneously in patients with scarlet fever failed to blanch the rash. The other four, Group B, were used as control subjects. Two had had scarlet fever, two had not. Samples of serum from all four produced a well marked area of blanching when injected intracutaneously in patients with scarlet fever.
0.3 cc. of each scarlet fever serum was injected intracutaneously in one or more members of Group A and the resulting reactions were carefully observed. 0.3 cc. of each serum that gave a positive reaction in members of Group A was injected similarly in one or more members of Group B.
Six of the serums gave marked positive reactions in members of Group A, negative reactions in members of Group B. Five gave moderate positive reactions in the more susceptible members of Group A, negative reactions in members of Group B. Six gave no reaction in the more susceptible members of Group A and were therefore not tested in members of Group B.
The positive reactions varied from very marked reactions showing areas of bright diffuse erythema, 50 to 70 mm. in diameter, moderately indurated and tender, of 3 or 4 days duration, followed by pigmentation and desquamation, to mild reactions of moderate diffuse or blotchy erythema, 20 to 30 mm. in diameter, not indurated or tender, of 24 to 48 hours duration, followed by transient pigmentation and no desquamation.
The details are presented in Table II . From the result of the foregoing test it is clear that there is a toxic substance present in the blood of many cases of scarlet fever in sufficient concentration to produce a clear-cut local reaction in the skin of normal individuals, provided the blood serum of those individuals gives a negative Schultz-Charlton rash extinction test in Reaction to intracutaneous injection of 0.3 co. of scarlet fever serum.
++ ++ + -++ -u + + + indicates strongly positive reaction, 50 to 70 mm. in diameter, bright red, moderately indurated and tender, of 3 to 4 days duration followed by pigmentation and desquamation; + +, positive reaction, 35 to 50 ram. in diameter, bright red, with slight induration, of 2 to 3 days duration, followed by moderate pigmentation and occasionally slight desquamation; +, moderately positive reaction, 20 to 35 mm. in diameter, red, no induration, of 1 to 2 days duration, with slight pigmentation and no desquamation; and -, no reaction.
cases of scarlet fever. It is furthermore evident from the variations in the intensity of the reactions, that the concentration of the toxic substance varies in different cases. It would also appear by comparison of the positive reactions in Volunteers F. G. B. and E. E. N. on the one hand with those in I. H. and E. McC. (Table II) on the other that individuals vary in their susceptibility. Correlation of the positive and negative reactions with the day of the disease on which the serum was collected is not apparent nor is there a strict correlation between the clinical severity of the cases and the toxic property of the serums. That the positive reactions were due to a toxic substance specifically related to scarlet fever is indicated by the fact that they occurred only in members of Group A, while all tests in members of Group B were completely negative. Further evidence in support of this view is provided in the following test.
Neutralization of the Toxic Substance in the Blood of Persons with Scarlet Fever by Human Serum Possessing the Property of Blanching the Rash in Scarlet Fever.
IV. The serums from scarlet fever patients (Nos. 1 to 11, Test III), all of which had given positive reactions, were used. Series A: three parts of each serum were mixed with two parts of normal human serum which had been shown not to blanch the rash in scarlet fever. Series B: three parts of each serum were similarly mixed with two parts of normal human serum which had been shown to blanch the rash in scarlet fever. Both series were incubated in a water bath at 37°C. for 30 minutes. 0.5 cc. of each mixture was injected intracutaneously in an individual of Group A, III (Volunteer F. G. B.) who had been shown to be susceptible to the toxic substance in scarlet fever serum. As shown in Table III Hence it may be stated that the toxic substance present in the blood of patients with scarlet fever is readily and completely neutralized by a human serum which produces a positive Schultz-Charlton 
Neutralization of Toxic Substance in Scarlet Fever Blood by Dochez's Scarlatinal

A ntistreptococcic Serum.
Scarlet fever serum case. Negative. sg rash extinction test. Failure to obtain complete neutralization in three of the eleven tests is not surprising when it is realized that the mixtures contained two unknown variables,--the toxic content of the scarlet fever serum and the anfitoxic content of the neutralizing serum.
Neutralization Tests with Dochez's Scarlatinal Antistreptococcic Serum.
Since it had been found by Blake, Trask, and Lynch14 that Dochez's scarlatinal antistreptococcic serum produces a marked blanching of the rash in scarlet fever similar to the Schultz-Charlton rash extinction phenomenon produced by convalescent scarlet fever serum and by some normal human serums, it seemed probable that Dochez's serum would neutralize the toxic substance in scarlet fever blood. After a few preliminary trials it soon became evident that a clear-cut result could be obtained only in an individual in whom an intracutaneous injection of normal horse serum produced no immediate or accelerated local serum reaction. Such an individual was finally found and the following test performed.
v. Volunteer I. M. W.; no history of scarlet fever; serum gives a negative blanching test. Scarlet Fever Serums 1, 4, and 5 (Test III) were used. Series A: three parts of each serum were mixed with two parts of a 1 : 10 saline dilution of normal horse serum. Series B : three parts of each serum were mixed with two parts of a 1 : 10 saline dilution of Dochez's antiscarlatinal horse serum. Both series were incubated in a water bath at 37°C. for 30 minutes. 0.5 cc. of each mixture was injected intracutaneously in Volunteer I. M.W. As shown in Table IV Series A produced positive reactions, while Series B showed no reactions.
This test not only shows that the toxic substance in scarlet fever blood is readily neutralized by Dochez's scarlafinal antistreptococcic serum, but it also provides evidence which supports the view that Dochez's serum is a specific scarlatinal antitoxic serum. It also suggests that Dochez's serum has a relatively high antitoxic content since 0.02 cc. of the serum completely neutralized 0.3 cc. of Scarlet Fever Serum 1 which was incompletely neutralized by 0.2 cc. of a human blanching serum (IV).
_Presence of a Toxic Substance in the Urine of Patients with
Inasmuch as a toxic substance was readily demonstrable in the blood of patients with scarlet fever, it seemed desirable to determine whether a similar substance might be found in the urine.
Accordingly the urine of five patients was studied by means of intracutaneous tests in human volunteers.
Since it was to be expected that pseudoreactions from other substances in the urine might obscure the results each test was controlled by a simultaneous neutralization test.
VI. Specimens of urine were collected from five patients with scarlet fever, filtered through Berkefeld filters, and tested for sterility. Parallel series of intracutaneous injections were made in four normal volunteers, three of whom had been shown to be susceptible to the toxic substance in scarlet fever blood, and one of whom served as an insusceptible control. Both series were incubated in a water bath at 37°C. for 30 minutes prior to injection. The actual amount of urine in the urine-serum mixtures injected varied from 0.02 to 0.2 cc. Reactions in Series A were considered positive only when they persisted for 48 hours or more and were followed by pigmentation or desquamation with negative reactions in Series B and in the insusceptible control at 48 hours. Moderate transient erythema of about 24 hours duration occurred with nearly all injections and was disregarded. As shown in Table V , two of the five cases, both of which had given positive reactions with their serums, gave strongly positive reactions in Series A with negative reactions in the controls. Three were negative in both series. The positive reactions were characterized by bright red erythema, 40 to 60,ram. in diameter, moderate induration and tenderness, were of 3 to 4 days duration, and were followed by pigmentation and desquamation.
The foregoing data show that a toxic substance can be demonstrated in the urine of some cases of scarlet fever. This substance is neutralized by human serum that blanches the rash of scarlet fever but not by human serum that fails to blanch the rash. It causes a well defined local reaction in the skin of individuals whose serums give a negative Schultz-Charlton rash extinction test, no reaction in persons whose serums give a positive rash extinction test. In these respects it is similar to the toxic substance found in the blood of scarlet fever patients. In the tests exceedingly small amounts of unconcentrated urine were employed in order to avoid confusion with false reactions. It seems probable that the toxic substance specifically related to scarlet fever will be found in most scarlet fever urines when a more ready method for its detection than that of intracutaneous tests in human beings is devised.
Daily Observations on the Presence of a Toxic Substance in the Blood and Urine of a Patient with Scarlet Fever.
The data so far reported have dealt with single observations on a series of patients. From the results obtained it has not been possible definitely to relate the presence or absence of the toxic substance in the blood and urine with the course of the disease. Furthermore, although there is in general a satisfactory agreement between the Z t o~ . It seemed desirable, therefore, to make daily observations on a series of cases in order to obtain more definite information concerning these points. One study of this kind has been completed and may properly be included here.
VII. Case N. G., male; age 6. Admitted to the hospital on the 2nd day of scarlet fever, about 27 hours after onset. Moderately severe. Samples of blood and urine were collected daily throughout the disease. These were tested by intracutaneous injections in susceptible human volunteers, with the appropriate insusceptible volunteer controls and control neutralization tests. 0.3 cc. of serum and 0.2 cc. of urine were used in the tests. Toxic substance was present in the blood from the 2nd to the 5th day, in the urine from the 3rd to the 6th day. The relation of its concentration as roughly measured by the severity of the local reactions in the test subjects to the course of the disease is shown in Chart 1.
SUMMARY.
A series of observations on the blood of patients acutely ill with scarlet fever has shown that a toxic substance can be demonstrated in the serum by means of intracutaneous injections of the serum in persons who have not had scarlet fever and whose serums fail to blanch the rash in scarlet fever. The reaction caused by this substance consists of a bright red local erythema, varying from 20 to 70 ram. in diameter, of 1 to 4 days duration. The severer reactions are moderately indurated and tender, and are followed by pigmentation and desquamation. Control injections in persons whose serums blanch the rash in scarlet fever cause no reaction. The toxic substance is not neutralized by mixture with a human serum which gives a negative blanching test but is readily neutralized by a human serum which gives a positive blanching test. It is not neutralized by normal horse serum, but is completely neutralized by Dochez's scarlatinal antistreptococcic serum.
In a limited number of observations on the urine of patients with scarlet fever a similar toxic substance has been found in two out of five cases studied.
Since the toxic substance described appears to resemble the toxic substance found in the filtrates of scarlatinal hemolytic streptococcus cultures by Dick and Dick and since it is neutralized not only by a blanching human serum but also by Dochez's scarlatinal antistreptococcic horse serum, the experiments reported support the conception that scarlet fever is a local infection of the throat by a particular type of Streptococcus hcemolyticus capable of producing a toxin which is absorbed and is the cause of the general manifestations of the disease. (Trask and Blake: Toxic substance in scarlet fever.)
